Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Pharma News > 2019 > Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy

Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy

PARIS (Reuters) - Pharmaceutical group Eli Lilly said on Tuesday it will cut 250 jobs at its factory located near Strasbourg in Eastern France.

The company said it will reduce its payroll at the plant through a voluntary redundancy plan.

Eli Lilly currently employs 1,400 workers at the plant.

JANUARY 8, 2019

https://www.reuters.com/

Read also

EC approves AstraZeneca’s Fasenra for EGPA treatment

EC approves AstraZeneca’s Fasenra for EGPA treatment

The European Commission (EC) has approved AstraZeneca‘s Fasenra (benralizumab) as an add-on therapy for adults with relapsing or refractory eosinophilic granulomatosis with polyangii...

Genprex reports positive preclinical gene therapy data

Genprex reports positive preclinical gene therapy data

Genprex, Inc., a clinical-stage gene therapy company, announced positive preclinical results for its lead drug candidate, Reqorsa® (quratusugene ozeplasmid) Gene Therapy, at the recent EORTC-...

Astellas withdraws Europe ACP application for AMD treatment

Astellas withdraws Europe ACP application for AMD treatment

Astellas Pharma has announced the withdrawal of its marketing authorisation application for IZERVAY (avacincaptad pegol, ACP) intravitreal solution to treat geographic atrophy (GA) sec...

New report demands greater understanding of the impact of change on academia

New report demands greater understanding of the impact of change on academia

Digital Science, a technology company serving stakeholders across the research ecosystem, is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having ...

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote